Noticias y eventos de Canopy Growth Corp (CGC)CGCCanopy Growth Corp

Canopy Growth Shareholders Approve Multiple Resolutions

Canopy Growth Corporation announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23. A total of 154,837,897 common shares of the Company, representing 36.60% of the issued and outstanding Shares, were voted in connection with the Meeting by the Company's shareholders . All of the matters put forward before the Shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 7, were approved by the requisite number of votes cast at the Meeting. Each of the directors of the Company's board of directors listed as a nominee in the Proxy Statement were elected at the Meeting to serve as a director of the Company until the Company's next annual shareholders meeting or until his or her successor is duly elected or appointed. Each of the directors of the Company's board of directors listed as a nominee in the Proxy Statement were elected at the Meeting to serve as a director of the Company until the Company's next annual shareholders meeting or until his or her successor is duly elected or appointed. Shareholders also approved the appointment of MNP as the Company's auditor and independent registered public accounting firm for the fiscal year ending March 31, 2027, and authorized the Board or any responsible committee thereof to fix MNP's remuneration.Shareholders adopted a special resolution authorizing an amendment to the articles of the Company to, among other things, consolidate the Company's issued and outstanding Shares and exchangeable shares of the Company on the basis of a ratio to be determined by the board of directors of the Company, in its sole discretion, within a range of one post-consolidation share for every five to fifteen outstanding pre-consolidation shares, as more particularly described in the Proxy Statement. The share consolidation will only be implemented, if at all, upon a determination by the Board that it is in the best interest of the Company and its Shareholders. If the Board does not implement the share consolidation within 12 months of the date of the Meeting, the authority granted to the Board will lapse and be of no further force or effect. Shareholders adopted an ordinary resolution ratifying and approving the adoption of the By-Law No. 2 of the Company, which establishes advance notice and certain other requirements for Shareholders proposing director nominations for Shareholder meetings of the Company, as more particularly described in the Proxy Statement. Shareholders adopted an ordinary resolution authorizing and approving all unallocated entitlements under the Company's Omnibus Incentive Plan, as more particularly described in the Proxy Statement.

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

Canopy Growth announced the appointment of Sebastian Blote as Country Manager for Germany, effective October 1, 2026. Blote will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections with partners and healthcare professionals, and driving growth to fully capture the significant potential of the German medical cannabis market. He most recently served as European Sales Director, then Digital Sales Director, at a leading European medical cannabis company based in Germany.

Canopy Growth Appoints Sebastian Blote as Country Manager for Germany

Canopy Growth announced the appointment of Sebastian Blote as Country Manager for Germany, effective October 1, 2026. Blote will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections with partners and healthcare professionals, and driving growth to fully capture the significant potential of the German medical cannabis market. He most recently served as European Sales Director, then Digital Sales Director, at a leading European medical cannabis company based in Germany.